
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
Author(s) -
E Georgescu,
Reanina Ionescu,
Mihaela Niculescu,
Laurenţiu Mogoantă,
Liliana Vancica
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.942
Subject(s) - steatohepatitis , medicine , gastroenterology , fatty liver , metabolic syndrome , valsartan , steatosis , insulin resistance , blood pressure , endocrinology , insulin , obesity , disease
To evaluate insulin resistance, cytolysis and non-alcoholic steatohepatitis (NASH) score (NAS) using the Kleiner and Brunt criteria in 54 patients with NASH and mild-to-moderate hypertension, treated with telmisartan vs valsartan for 20 mo.